ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel
  • »
  • Health»
  • Men's Health & Wellness

Aggressive, Unnecessary Treatment for Prostate Cancer! Caution!

Updated on March 25, 2012
When it comes to prostate cancer, take a "time out" to review your treatment options before proceeding.
When it comes to prostate cancer, take a "time out" to review your treatment options before proceeding.

Prostate Cancer: Beware Unnecessary Treatment!

Prostate cancer is the second most common cancer among men, second to lung cancer. Many times, however, the cancer is non-threatening--yet many men receive aggressive and unnecessary treatments. These include surgery, and radiation and hormone therapy, all of which may cause unpleasant and life-altering side-effects like impotence and incontinence.

So how could this happen?

Lowering the PSA standard could have devastating results.
Lowering the PSA standard could have devastating results.

The Problem Is... The PSA Test...

Men receive a simple blood test to detect prostate cancer. it's called a PSA, and it looks for a prostate-specific antigen in the blood that signals the disease. Four nanograms of PSA per milliter of blood is considered normal, but unfortunately men are being diagnosed with prostate cancer when their levels are below the norm.

Dr. Shao, of the Cancer Institute of New Jersey, conducted a study analyzing the treatment of over 100,000+ men with prostate cancer. They found that 44% of men with normal or lower PSA levels had their prostates removed and 33% had radiation.

In another study, it was determined that about one-million men were treated for prostate tumors when the disease would not have effected them.

And there's another issue: Some scientists want to reduce the standard for the PSA test from four to 2.5 nanograms per milliter of blood with devastating consequences.

"Stop" aggressive treatment if your PSA is normal or below.
"Stop" aggressive treatment if your PSA is normal or below.

The PSA Test Should NOT be the Only Indicator... Here's Why...

Should the standard lower from four to 2.5 nanograms per milliliter of blood, the number of men considered to have abnormal PSA levels would double to six million. Dr. Shao estimates that about two million of them would get aggressive treatment, while only about two-percent would have high-grade cancer.

"These results underscore the fact that PSA level, the current biomarker, is not a sufficient basis for treatment decisions," said Shao.

The study was published in the Archives of Internal Medicine.




Smart patients get second opinions!
Smart patients get second opinions!

Madam Aphrodite™ Speaks...

Men are regularly screened for PSA and if yours is close to the norm or lower, beware of unnecessary, aggressive treatments (if suggested) that can be hazardous to your health.

CAUTION: If your doctor suggests these treatments to you, and your PSA is within the normal range or lower, always get a second opinion before proceeding. And please, show this study to your doctor!

CAUTION: The information included herein is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her healthcare provider to determine the appropriateness of the information for their own situation or if they have any questions regarding a medical condition or treatment plan.


Comments

    0 of 8192 characters used
    Post Comment

    • Madam Aphrodite profile image
      Author

      Madam Aphrodite 6 years ago from USA

      Excellent! Thank you.

    • conradofontanilla profile image

      conradofontanilla 6 years ago from Philippines

      There should be a proxy indicator of the risk of prostate cancer. I suggest level of selenium. The norm seems to be that half the body's supply is found in the prostate gland. (I have a Hub "An Alternative Approach to and Therapy For Prostate Cancer") If one's body content of selenium is below the norm, that is a warning that one lacks protection against prostrate cancer. The counter is to up one's supply. The framework of PSA is germ theory of disease when it should be the free radical theories of disease because cancer is caused by free radicals not by germs. Selenium, by itself is a scavenger of free radicals. It combines with other elements to form part of the enzyme antioxidant system of glutathione. Glutathione peroxidase dismantles the hydrogen peroxide that resulted from the combination of superoxides, by-products of glucose metabolism. Hydrogen peroxide is a reactive oxygen species that acts like a free radical (Sharma, H., MD. Freedom from Disease. 1996). The best way to deal with prostate cancer is prevention; the means to do it is now available and cheap. The mechanism of free radical production in the cell, including those of the prostate gland is: metabolism of glucose produces superoxides; superoxide combines with hydrogen proton and one hydrogen atom catalyzed by superoxide dismutase resulting in hydrogen peroxide; this is dismantled by glutathione peroxidase; this is recycled by glutathione reductase. Glutathione is synthesized by glutathione synthetase out of glutamate, cysteine, cystine and cofactors B2, lipoic acid, zinc and selenium from nutrition. When PSA is positive, it means that free radicals had inflicted damage.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: "https://hubpages.com/privacy-policy#gdpr"

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)